A new study suggests that semaglutide, a popular diabetes medication, could be linked to a lower risk of opioid overdose in patients with type 2 diabetes and opioid use disorder. This finding could open doors for a new use of this blockbuster drug, but more research is needed to confirm its efficacy and investigate the underlying mechanisms.
The global opioid overdose treatment market is projected to reach US$ 3.1 billion by 2034, driven by the rising number of opioid overdose cases and the development of new, more effective treatment solutions. North America is the largest market, with the US leading the region, and the increasing popularity of opioid antagonists is driving market growth. Key players in the industry are focusing on innovation and developing advanced treatment options.
